UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 15

 

CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER

SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSIONx

OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934.

 

Commission File Number 000-56140

 

NP Life Sciences Health Industry Group Inc.

 

(Exact name of registrant as specified in its charter)

 

4125 Blackhawk Plaza Circle, Suite 166

Danville, CA 94506

(925) 362-3169

 

(Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)

 

Common stock, $0.0001 par value

 

(Title of each class of securities covered by this Form)

 

None

 

(Titles of all other classes of securities for which a duty to file reports under section 13(a) or 15(d) remains)

 

Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:

 

  Rule 12g-4(a)(1) ☐
  Rule 12g-4(a)(2) ☐
  Rule 12h-3(b)(1)(i) ☒
  Rule 12h-3(b)(1)(ii) ☐
  Rule 15d-6 ☐

 

Approximate number of holders of record as of the certification or notice date: 59

 

Pursuant to the requirements of the Securities Exchange Act of 1934, NP Life Sciences Health Industry Group Inc. has caused this certification/notice to be signed on its behalf by the undersigned duly authorized person.

 

Date: May 13, 2024 By: /s/ Guidong Wang
    Guidong Wang
    (Chief Executive Officer)

 

SEC 2069 (08-11) Potential persons who are to respond to the collection of information contained in this Form are not required to respond unless the Form displays a currently valid OMB control number.

 

Instruction: This form is required by Rules 12g-4, 12h-3, 15d-6 and 15d-22 of the General Rules and Regulations under the Securities Exchange Act of 1934. The registrant shall file with the Commission three copies of Form 15, one of which shall be manually signed. It may be signed by an officer of the registrant, by counsel or by any other duly authorized person. The name and title of the person signing the form shall be typed or printed under the signature.

 

 

 

NP Life Sciences Health ... (QB) (USOTC:NPLS)
Gráfica de Acción Histórica
De Abr 2024 a May 2024 Haga Click aquí para más Gráficas NP Life Sciences Health ... (QB).
NP Life Sciences Health ... (QB) (USOTC:NPLS)
Gráfica de Acción Histórica
De May 2023 a May 2024 Haga Click aquí para más Gráficas NP Life Sciences Health ... (QB).